Makoto Takei Selected Research

Makoto Takei Research Topics

Disease

19	Heart Failure 02/2024 - 05/2015
5	Pulmonary Arterial Hypertension 12/2023 - 01/2012
4	Pulmonary Hypertension 01/2017 - 03/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 10/2021
3	Neoplasms (Cancer) 10/2014 - 10/2009
3	Breast Neoplasms (Breast Cancer) 01/2012 - 07/2010
2	Death (Near-Death Experience) 05/2024 - 10/2022
2	Coronary Artery Disease (Coronary Atherosclerosis) 08/2023 - 08/2016
2	Malnutrition (Nutritional Deficiencies) 01/2023 - 01/2022
2	Hypertension (High Blood Pressure) 01/2019 - 01/2017
2	Muscular Dystrophies (Muscular Dystrophy) 06/2015 - 04/2015
2	Human Influenza (Influenza) 01/2014 - 05/2011
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2014 - 12/2010
1	Hypotension (Low Blood Pressure) 01/2023
1	Hyperkalemia 12/2022
1	Hypokalemia 12/2022
1	Rupture 01/2021
1	Atrial Fibrillation 08/2020
1	Hyponatremia 08/2019
1	Anemia 08/2019
1	Chronic Renal Insufficiency 08/2019
1	Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy) 01/2017
1	Apnea 01/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2016
1	Hypoxia (Hypoxemia) 12/2016
1	Type 2 Diabetes Mellitus (MODY) 12/2016
1	Cerebral Infarction 12/2016
1	Atherosclerosis 08/2016
1	Parkinson Disease (Parkinson's Disease) 01/2016
1	Central Nervous System Diseases (CNS Diseases) 01/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016
1	Neuroinflammatory Diseases 01/2016
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2016
1	Pneumonia (Pneumonitis) 01/2016
1	Non-alcoholic Fatty Liver Disease 01/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2015
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2015

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2017 - 06/2010
4	DiureticsIBA 02/2024 - 05/2015
3	Sodium-Glucose Transport ProteinsIBA 01/2023 - 12/2016
2	Furosemide (Lasix)FDA LinkGeneric 02/2024 - 10/2022
2	empagliflozinIBA 01/2023 - 12/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 12/2016
2	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2019 - 01/2016
2	NitrogenIBA 08/2019 - 01/2016
2	Urea (Carbamide)FDA LinkGeneric 08/2019 - 01/2016
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2015 - 04/2015
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2015 - 01/2012
2	Oseltamivir (Tamiflu)FDA Link 01/2014 - 05/2011
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2011 - 07/2010
1	Torsemide (Demadex)FDA LinkGeneric 02/2024
1	sacubitril and valsartan sodium hydrate drug combinationIBA 02/2024
1	dapagliflozinIBA 02/2024
1	Dihydrotachysterol (AT 10)IBA 11/2023
1	LipidsIBA 08/2023
1	pitavastatin (itavastatin)FDA Link 08/2023
1	oxidized low density lipoproteinIBA 08/2023
1	LDL CholesterolIBA 08/2023
1	PotassiumIBA 12/2022
1	Blood Glucose (Blood Sugar)IBA 10/2022
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 10/2022
1	IvabradineIBA 01/2022
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022
1	Steroid Receptors (Steroid Receptor)IBA 01/2022
1	MineralsIBA 01/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022
1	Neprilysin (Neutral Endopeptidase)IBA 01/2022
1	Vasodilator Agents (Vasodilators)IBA 08/2020
1	Trinitrotoluene (TNT)IBA 01/2017
1	Carbon MonoxideIBA 01/2017
1	emerinIBA 01/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2016
1	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2016
1	Erythropoietin FDA Link 12/2016
1	Oxygen (Dioxygen)IBA 12/2016
1	CholesterolIBA 08/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2016
1	Everolimus FDA Link 08/2016
1	ChemokinesIBA 08/2016
1	C-Reactive ProteinIBA 08/2016
1	Rosuvastatin Calcium (Crestor)FDA Link 08/2016
1	metabotropic glutamate receptor type 1IBA 01/2016
1	alpha-SynucleinIBA 01/2016
1	SodiumIBA 01/2016
1	Antidiuretic Hormone Receptor AntagonistsIBA 07/2015
1	Tolvaptan FDA Link 07/2015
1	Contrast MediaIBA 06/2015
1	Phosphodiesterase 5 InhibitorsIBA 05/2015
1	Amino Acids FDA Link 03/2015
1	hydralazine 4-anisaldehyde hydrazoneIBA 01/2015

Therapy/Procedure

11	Therapeutics 12/2023 - 01/2014
2	Patient Readmission 05/2024 - 10/2022
2	Drug Therapy (Chemotherapy) 11/2023 - 06/2010
1	Terminal Care (Care, Terminal) 01/2022
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 10/2021
1	Hospice Care (Care, Bereavement) 10/2021
1	Transcatheter Aortic Valve Replacement 01/2021
1	Glycemic Control 09/2018
1	Stents 08/2016
1	Intravenous Infusions 01/2015